Suppr超能文献

新辅助免疫治疗后局部晚期胃癌行微创胃切除术的安全性和可行性:中国一项倾向评分匹配分析

Safety and feasibility of minimally invasive gastrectomy after neoadjuvant immunotherapy for locally advanced gastric cancer: a propensity score-matched analysis in China.

作者信息

Cui Hao, Liang Wenquan, Cui Jianxin, Song Liqiang, Yuan Zhen, Chen Lin, Wei Bo

机构信息

School of Medicine, Nankai University, Tianjin, P. R. China.

Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, P. R. China.

出版信息

Gastroenterol Rep (Oxf). 2024 Feb 28;12:goae005. doi: 10.1093/gastro/goae005. eCollection 2024.

Abstract

BACKGROUND

The effect of neoadjuvant immunotherapy on minimally invasive gastrectomy (MIG) for locally advanced gastric cancer (LAGC) remains controversial. This study aimed to compare short-term outcomes between MIG after neoadjuvant chemo-immunotherapy (NICT-MIG) and MIG after neoadjuvant chemotherapy alone (NCT-MIG), and determine risk factors for post-operative complications (POCs).

METHODS

This retrospective study included clinicopathologic data from 193 patients who underwent NCT-MIG or NICT-MIG between January 2020 and February 2023 in the Department of General Surgery, Chinese People's Liberation Army General Hospital First Medical Center (Beijing, China). Propensity score-matched analysis at a ratio of 1:2 was performed to reduce bias from confounding patient-related variables and short-term outcomes were compared between the two groups.

RESULTS

The baseline characteristics were comparable between 49 patients in the NICT-MIG group and 86 patients in the NCT-MIG group after propensity score matching. Objective and pathologic complete response rates were significantly higher in the NICT-MIG group than in the NCT-MIG group (<0.05). The overall incidence of treat-related adverse events, intraoperative bleeding, operation time, number of retrieved lymph nodes, time to the first flatus, post-operative duration of hospitalization, overall morbidity, and severe morbidity were comparable between the NCT-MIG and NICT-MIG groups ( > 0.05). By multivariate logistic analysis, estimated blood loss of >200 mL (=0.010) and prognostic nutritional index (PNI) score of <45 (=0.003) were independent risk factors for POCs after MIG following neoadjuvant therapy.

CONCLUSIONS

Safety and feasibility of NICT were comparable to those of NCT in patients undergoing MIG for LAGC. Patients with an estimated blood loss of >200 mL or a PNI score of <45 should be carefully evaluated for increased POCs risk.

摘要

背景

新辅助免疫治疗对局部晚期胃癌(LAGC)行微创胃切除术(MIG)的疗效仍存在争议。本研究旨在比较新辅助化疗联合免疫治疗后行MIG(NICT-MIG)与单纯新辅助化疗后行MIG(NCT-MIG)的短期结局,并确定术后并发症(POC)的危险因素。

方法

本回顾性研究纳入了2020年1月至2023年2月在中国人民解放军总医院第一医学中心(北京,中国)普通外科接受NCT-MIG或NICT-MIG的193例患者的临床病理数据。进行1:2比例的倾向评分匹配分析,以减少患者相关混杂变量的偏倚,并比较两组的短期结局。

结果

倾向评分匹配后,NICT-MIG组的49例患者与NCT-MIG组的86例患者的基线特征具有可比性。NICT-MIG组的客观缓解率和病理完全缓解率显著高于NCT-MIG组(<0.05)。NCT-MIG组和NICT-MIG组在治疗相关不良事件的总发生率、术中出血、手术时间、获取淋巴结数量、首次排气时间、术后住院时间、总体发病率和严重发病率方面具有可比性(>0.05)。通过多因素逻辑分析,估计失血量>200 mL(=0.010)和预后营养指数(PNI)评分<45(=0.003)是新辅助治疗后MIG术后POC的独立危险因素。

结论

对于接受LAGC的MIG患者,NICT的安全性和可行性与NCT相当。估计失血量>200 mL或PNI评分<45的患者应仔细评估POC风险增加的情况。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验